Latest News

Cesca Therapeutics’  “Buy” Rating Reaffirmed at HC Wainwright
Cesca Therapeutics’ “Buy” Rating Reaffirmed at HC Wainwright
Nice  Raised to Buy at Zacks Investment Research
Nice Raised to Buy at Zacks Investment Research
Zacks Investment Research Upgrades FOX  to “Hold”
Zacks Investment Research Upgrades FOX to “Hold”
ValuEngine Lowers Iclick Interactive Asia Group  to Hold
ValuEngine Lowers Iclick Interactive Asia Group to Hold
Cortexyme  Upgraded to “Buy” at Zacks Investment Research
Cortexyme Upgraded to “Buy” at Zacks Investment Research
Ashford Hospitality Trust  Receives “Buy” Rating from Deutsche Bank
Ashford Hospitality Trust Receives “Buy” Rating from Deutsche Bank


 
© 2006-2019 Zolmax.